0.7481
                                            Schlusskurs vom Vortag:
              $0.7788
            Offen:
              $0.7849
            24-Stunden-Volumen:
                2.24M
            Relative Volume:
              1.64
            Marktkapitalisierung:
                $73.80M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-93.61M
            KGV:
              -0.3545
            EPS:
                -2.11
            Netto-Cashflow:
                $-71.16M
            1W Leistung:
              -10.41%
            1M Leistung:
              -23.53%
            6M Leistung:
                -34.95%
            1J Leistung:
              -37.13%
            Immunic Inc Stock (IMUX) Company Profile
Firmenname
                  
                      Immunic Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      (332) 255-9818
                    
                Adresse
                  
                      1200 AVENUE OF THE AMERICAS, NEW YORK
                    
                Vergleichen Sie IMUX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                IMUX
                            
                             
                        Immunic Inc 
                           | 
                    0.7481 | 76.83M | 0 | -93.61M | -71.16M | -2.11 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy | 
| 2025-03-25 | Eingeleitet | William Blair | Outperform | 
| 2024-11-25 | Eingeleitet | H.C. Wainwright | Buy | 
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform | 
| 2024-08-27 | Eingeleitet | B. Riley Securities | Buy | 
| 2022-10-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform | 
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy | 
| 2021-04-15 | Eingeleitet | Aegis Capital | Buy | 
| 2021-03-24 | Eingeleitet | JMP Securities | Mkt Outperform | 
| 2020-10-02 | Eingeleitet | SVB Leerink | Outperform | 
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight | 
| 2020-08-07 | Fortgesetzt | ROTH Capital | Buy | 
| 2020-07-20 | Eingeleitet | BMO Capital Markets | Outperform | 
| 2020-06-05 | Eingeleitet | Wedbush | Outperform | 
| 2020-05-11 | Eingeleitet | H.C. Wainwright | Buy | 
| 2020-03-25 | Eingeleitet | ROTH Capital | Buy | 
| 2019-07-11 | Eingeleitet | Chardan Capital Markets | Buy | 
                    Alle ansehen
                    
                  
                Immunic Inc Aktie (IMUX) Neueste Nachrichten
Why Immunic Inc. stock is trending among retail tradersQuarterly Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
Will Immunic Inc. (10VA) stock outperform global peersGap Up & Consistent Profit Focused Trading Strategies - newser.com
Forecasting Immunic Inc. price range with options data2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Is Immunic Inc. stock a top momentum playJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
Evaluating Immunic Inc. with trendline analysis2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
What does recent volatility data suggest for Immunic Inc.2025 Key Lessons & AI Driven Price Predictions - newser.com
Is Immunic Inc. (10VA) stock a momentum leader2025 Earnings Surprises & Verified Entry Point Signals - newser.com
Is Immunic Inc. stock resilient to inflationTrade Signal Summary & Technical Pattern Based Signals - newser.com
What high frequency data says about Immunic Inc.July 2025 Levels & Real-Time Stock Entry Alerts - newser.com
News impact scoring models applied to Immunic Inc.Volume Spike & Daily Growth Stock Tips - newser.com
Will Immunic Inc. stock see PE expansionWall Street Watch & Long-Term Investment Growth Plans - newser.com
Is Immunic Inc. (10VA) stock positioned for secular growthTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Immunic to Participate in Industry and Investor Conferences in November - Sahm
Immunic (IMUX) Price Target Decreased by 17.29% to 6.41 - MSN
Price momentum metrics for Immunic Inc. explainedJuly 2025 EndofMonth & Capital Protection Trading Alerts - newser.com
Immunic, Inc. (IMUX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
What sentiment indicators say about Immunic Inc. stockQuarterly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Immunic (IMUX) to Release Quarterly Earnings on Thursday - MarketBeat
Why Immunic Inc. (10VA) stock benefits from AI revolutionWeekly Investment Recap & Verified Stock Trade Ideas - newser.com
Is Immunic Inc. stock supported by strong fundamentalsWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Is Immunic Inc. stock attractive for growth ETFs2025 Top Gainers & Fast Moving Stock Trade Plans - newser.com
EQS-News: Immunic to Participate in Industry and Investor Conferences in November - sharewise.com
EQS-News: Immunic AG: Immunic to Participate in Industry and Investor Conferences in November - FinanzNachrichten.de
Immunic (NASDAQ: IMUX) to join BIO-Europe Vienna and Jefferies London in November - Stock Titan
Immunic to participate in BIO-Europe and Jefferies Global Healthcare conferences in November - Proactive financial news
Will Immunic Inc. stock continue dividend increases2025 EndofYear Setup & Growth Focused Investment Plans - Fundação Cultural do Pará
Finanzdaten der Immunic Inc-Aktie (IMUX)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):